Literature DB >> 16672135

The epidemiology of self-reported fibromyalgia in Canada.

J Dayre McNally1, Doug A Matheson, Volodko S Bakowsky.   

Abstract

Fibromyalgia (FM) is a poorly understood condition characterized by chronic diffuse musculoskeletal pain. This study describes the self-reported epidemiology of FM in Canada using data collected from the Canadian Community Health Survey, Cycle 1.1 (2000). FM prevalence rates with corresponding 95 percent confidence intervals were calculated. The Canadian prevalence rate was 1.1 percent with a female-to-male ratio of six to one. In women, rates increased with age up to 65 years, declining thereafter. Data collected on-age-at- diagnosis is presented and demonstrates a surprising number of newly diagnosed FM cases among people in their 20s and 30s, signifying that FM is a problem for people of all ages. The association with FM and a number of sub-populations was also investigated. With respect to geography and environment, the FM prevalence rate in women was shown to be approximately two percent in all Canadian regions except Quebec, where it was 1.1 percent. Further analysis by language suggested that geographical and cultural differences might best explain this observation. Finally, an association with a number of behavioral and socioeconomic determinants of health, including weight, is presented.

Entities:  

Mesh:

Year:  2006        PMID: 16672135

Source DB:  PubMed          Journal:  Chronic Dis Can        ISSN: 0228-8699


  26 in total

1.  A potential relationship between diffuse musculoskeletal pain and hypogonadism.

Authors:  Jaclyn K Anderson; Rebecca Tuetken; Valerie Hoffman
Journal:  BMJ Case Rep       Date:  2010-01-13

Review 2.  Worldwide epidemiology of fibromyalgia.

Authors:  Luiz Paulo Queiroz
Journal:  Curr Pain Headache Rep       Date:  2013-08

3.  Clinical utility of the Hospital Anxiety and Depression Scale (HADS) for an outpatient fibromyalgia education program.

Authors:  Seungree Nam; Diane Tin; Lorna Bain; J Carter Thorne; Liane Ginsburg
Journal:  Clin Rheumatol       Date:  2013-09-01       Impact factor: 2.980

Review 4.  Aerobic exercise in fibromyalgia: a practical review.

Authors:  Eric N Thomas; Francis Blotman
Journal:  Rheumatol Int       Date:  2010-03-26       Impact factor: 2.631

5.  Chronic fatigue syndrome and fibromyalgia in Canada: prevalence and associations with six health status indicators.

Authors:  C Rusu; M E Gee; C Lagacé; M Parlor
Journal:  Health Promot Chronic Dis Prev Can       Date:  2015-03       Impact factor: 3.240

Review 6.  Fibromyalgia: evolving concepts over the past 2 decades.

Authors:  Mary-Ann Fitzcharles; Peter A Ste-Marie; John X Pereira
Journal:  CMAJ       Date:  2013-05-06       Impact factor: 8.262

7.  Reliability and validity of the Spanish version of the Pittsburgh Sleep Quality Index (PSQI) in patients with fibromyalgia.

Authors:  Fidel Hita-Contreras; Emilio Martínez-López; Pedro A Latorre-Román; Francisco Garrido; María A Santos; Antonio Martínez-Amat
Journal:  Rheumatol Int       Date:  2014-02-08       Impact factor: 2.631

8.  Individuals with fibromyalgia and depression: findings from a nationally representative Canadian survey.

Authors:  Esme Fuller-Thomson; Jodie Nimigon-Young; Sarah Brennenstuhl
Journal:  Rheumatol Int       Date:  2011-01-08       Impact factor: 2.631

Review 9.  Gabapentin for chronic neuropathic pain and fibromyalgia in adults.

Authors:  R Andrew Moore; Philip J Wiffen; Sheena Derry; Thomas Toelle; Andrew S C Rice
Journal:  Cochrane Database Syst Rev       Date:  2014-04-27

Review 10.  Resistance exercise training for fibromyalgia.

Authors:  Angela J Busch; Sandra C Webber; Rachel S Richards; Julia Bidonde; Candice L Schachter; Laurel A Schafer; Adrienne Danyliw; Anuradha Sawant; Vanina Dal Bello-Haas; Tamara Rader; Tom J Overend
Journal:  Cochrane Database Syst Rev       Date:  2013-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.